Author:
Bolick S C E,Landowski T H,Boulware D,Oshiro M M,Ohkanda J,Hamilton A D,Sebti S M,Dalton W S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference26 articles.
1. Hallek M, Bergsagel PL & Anderson KC . Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21.
2. Neri A, Murphy JP, Cro L, Ferrero D, Tarella C, Baldini L & Dalla-Favera R . Ras oncogene mutation in multiple myeloma. J Exp Med 1989; 170: 1715–1725.
3. Liu P, Leong T, Quam L, Billadeau D, Kay NE, Greipp PR, Kyle RA, Oken MM & Van Ness B . Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group phase III trial. Blood 1996; 88: 2699–2706.
4. Portier M, Moles J-P, Mazars G-R, Jeanteur P, Bataille R, Klein B & Theillet C . p53 and RAS gene mutations in multiple myeloma. Oncogene 1992; 7: 2539–2543.
5. Rowley M, Liu P & Van Ness B . Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan. Blood 2000; 96: 3175–3180.
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献